Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer
NCT02468284
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
degarelix
Sponsor
Ferring Pharmaceuticals